FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...

Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread ...

Jan 19 () - Pharmaceutical company Boehringer Ingelheim said on Monday the U. Food and Drug ​Administration had approved its ...

The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...

Previously known as vapor rub, the Kamay ni Nanay Baby Balm retains the same formulation and efficacy, now presented under a ...

OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...

It's not a drug, and it may also have some benefits to quell overeating—here's how tech is transforming mental health care.

The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

On Wednesday, radiology AI company Aidoc announced the FDA has cleared a tool that can triage 14 critical findings in a ...

The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.

The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...